Markers of environmental tobacco smoke (ETS) exposure;Les marqueurs d'exposition au tabagisme passif

Revue des Maladies Respiratoires

Volumn 22, Issue 1, 2005, Pages 81-92

  Metz Favre, C ^a   Donnay, C ^a   De Blay, F ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Cotinine; Indoor environment; Nicotine; Passive smoking

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; COTININE; DNA; NICOTINE; PROTEIN; THIOCYANATE; TOBACCO SMOKE;

AIR POLLUTANT; AMBIENT AIR; BLOOD LEVEL; CIGARETTE SMOKING; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HAIR LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NAIL; PASSIVE SMOKING; RADIOIMMUNOASSAY; REVIEW; SALIVA LEVEL; SUSPENDED PARTICULATE MATTER; URINE LEVEL;

EID: 16444373465     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(05)85439-7     Document Type: Review

References (79)

1. Guerin MR, Jenkins RA, Tomkins BA: The chemistry of environmental tobacco smoke: composition and measurement. Chelsea, MI: Lewis Publishers 1992.
2. Dautzenberg: Le tabagisme passif. Paris: La documentation Française; 2001.
3. Prignot J: Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis 1987; 70: 1-7.
4. IARC Monographs programme on the evaluation of the carcinogenic risk of chemicals to humans. Preamble. IARC Monogr Eval Carcinog Risk Chem Hum 1986; 39: 13-32.
5. Zmirou D, Blatier JF, Andre E, Ferley JP, Balducci F, Rossum F, Delormas P: Passive smoking respiratory risk. A quantitative synthesis of the literature. Rev Mal Respir 1990; 7: 361-71.
6. Tredaniel J, Hill C, Chastang C, Hirsch A: Passive smoking and respiratory diseases. Current data. Rev Mal Respir 1989; 6: 109-20.
7. Charpin D: Le tabagisme passif. Méd Hyg 1984; 42: 3009-17.
8. http://www.official-documents.co.uk/document/doh/tobacco.htm.
9. http://tc.bmjjournals.com/cgi/collection/Environmental_tobacco_smoke.
10. http://www.epa.gov/ncea/etsindex.htm.
11. http://www.fctc.org.
12. Leaderer BP, Hammond SK: An Evaluation of Vapor Phase Nicotine and Respirable Suspended Particule Mass as Markers for Environmental Tobacco Smoke. Environ Sci and Technol 1991; 25: 770-7.
13. Leaderer BP: Assessing exposures to environmental tobacco smoke. Risk Anal 1990; 10: 19-26.
14. Hammond SK, Leaderer BP, Roche AC: Collection and analysis of nicotine as a marker for environmental tobacco smoke. Atmosph Envir 1987: 457-62.
15. Rickert WS, Robinson JC, Collishaw NE: Yields of tar, nicotine and carbon monoxide in the sidestream smoke from 15 brands of Canadian cigarettes. Am J Public Health 1984: 228-31.
16. Hyvarinen MJ, Rothberg M, Kahkonen E, Mielo T, Reijula K: Nicotine and 3-erhenylpyridine concentrations as markers for environmental tobacco smoke in restaurants. Indoor Air 2000; 10: 121-5.
17. Muramatsu M, Umemura S, Okada T: Estimation of personal exposure to tobacco smoke with a newly developed nicotine personal monitor. Envir Res 1984; 35: 218-27.
18. Respiratory Health Effects of passive Smoking: http://www.epa.gov/ncea/ etsindex.htm 2000; part 3: estimation of environmental tobacco smoke exposure.
19. Bergman TA, Johnson DL, Boatright DT, Smallwood KG, Rando RJ: Occupational exposure of nonsmoking nightclub musicians to environmental tobacco smoke. Am Ind Hyg Assoc 1996; 57: 746-52.
20. Piadé JJ, D'Andrés S, Sanders EB: Sorption phenomena of nicotine and ethenylpyridine vapors on different materials in a test chamber. Environ Sci Technol 1999; 33: 2046-52.
21. Vainiotalo S, Vaaranrinta R, Tornaeus J, Aremo N, Hase T, Peltonen K: Passive monitoring method for 3-ethenylpyridine: a marker for environmental tobacco smoke. Environ Sci Technol 2001: 1818-22.
22. Daisey JM, Mahanama KRR, Hodgson AT: Toxic volatile organic compounds in simulated environmental tobacco smoke: emission for exposure assessment. J Exp Anal Environ Epidemiol 1998; 8: 313-34.
23. Heavner DL, Morgan WT, Ogden MW: Determination of volatile organic compounds and ETS apportionment in 49 homes. Environ Int 1995: 3-21.
24. Ogden MW, Maiolo KC: Comparative evaluation of diffuse and active sampling systems for determining airborne nicotine and 3-ethenylpyridine. Environ Sci Technol 1992; 26: 1226-34.
25. Ogden MW, Heavner DL, Foster TL, et al.: Personal monitoring system for measuring environmental tobacco smoke exposure. Environ Sci Technol 1996; 17: 239-50.
26. Repace JL, Lowrey AH: An Indoor Air Quality Standard For Ambient Tobacco Smoke based on carcinogenic risk. NY State J Med 1985: 381-3.
27. Miesner EA, Rudnick L, Preller L, Nelson W: Paniculate and Nicotine Sampling in Public Facilities and Offices. JAPCA 1989; 39: 1577-82.
28. Gordon SM, Wallace LA, Brinkmann MC, Callahan PJ, Kenny DV: Volatile Organic Compounds as Breath Biomarkers for Active and Passive Smoking. Envir Health Pers 2002; 110: 689-98.
29. Wallace LA: Major sources of exposure to benzene and other volatile organic compounds. Risk Anal 1990; 10: 59-04.
30. Jarvis MJ, Russel MAH: Measurement and estimation of smoke dosage to non-smokers from environmental tobacco smoke. Eur J Resp Dis 1984; 133: 68-75.
31. Jarvis MJ, Russel MAH, Feyerabend C: Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. Thorax 1983; 38: 229-33.
32. Berny C, Boyer JC, Capolaghi B, L'Homme GD, Desch G, Garelik D, Hayder R, Houdret N, Jacob N, Koskas T, Laine G, Moel GL, Moulsma M, Plantin-Carrenard E, Venembre P: Biomarkers of tobacco smoke exposure. Ann Biol Clin 2002; 60: 263-72.
33. Messina ES, Tyndale RF, Sellers EM: A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997; 282: 1608-14.
34. rd, Fong I, Gupta S: Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994; 268: 296-303.
35. Benowitz NL: Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18: 188-204.
36. Haley NJ, Sepkovic DW, Hoffmann D: Elimination of cotinine from body fluids: disposition in smokers and nonsmokers. Am J Public Health 1989; 79: 1046-8. Epidemiol Rev 1996; 18: 188-204.
37. Haley NJ, Sepkovic DW, Hoffmann D: Elimination of cotinine from body fluids: disposition in smokers and nonsmokers. Am J Public Health 1989; 79: 1046-8. Epidemiol Rev 1996; 18: 188-204.
38. Henderson FW, Reid HF, Morris R, Wang OL, Hu PC, Helms RW, Forehand L, Mumford J, Lewtas J, Haley NJ: Home air nicotine levels and urinary cotinine excretion in preschool children. Am Rev Respir Dis 1989; 140: 197-201.
39. Haufroid V, Lison D: Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998; 71: 162-8.
40. Feyerabend C, Russell MA: Rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst 1980; 105: 998-1001.
41. Langone JJ, Gjika HB, Van Vunakis H: Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry 1973; 12; 5025-30.
42. Wald NJ, Boreham J, Bailey A, Ritchie C, Haddow JE, Knight G: Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet 1984; 1: 230-1.
43. Knight GJ, Wylie P, Holman MS, Haddow JE: Improved 1251 radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem 1985; 31: 118-21.
44. Kuo HW Yang JS, Chiu MC: Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 768: 297-303.
45. Schepers G, Walk RA: Cotinine determination by immunoassays may be influenced by other nicotine metabolites. Arch Toxicol 1988; 62: 395-7.
46. Watts RR, Langone JJ, Knight GJ, Lewtas J: Cotinine analytical workshop report: consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environ Health Perspect 1990; 84: 173-82.
47. Letzel H, Fischer-Brandies A, Johnson LC, Uberla K, Bibet A: Measuring problems in estimating the exposure to passive smoking using the excretion of cotinine. Toxicol Lett 1987; 35: 35-44.
48. Pirkle JL, Flegal KM, Bernett JT, Brody DJ, Etzel RA, Maurer KR: Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996; 275: 1233-40.
49. Matsukura S, Sakamoto N, Takahashi K, Matsuyama H, Muranaka H: Effect of pH and urine flow on urinary nicotine excretion after smoking cigarettes. Clin Pharmacol Ther 1979; 25: 549-54.
50. Johnson LC, Letzel H, Kleinschmidt J: Passive smoking under controlled conditions. Int Arch Occup Environ Health 1985; 56: 99-110.
51. Matsukura S, Taminato T, Kitano N, Seino Y, Hamada H, Uchihashi M, Nakajima H, Hirata Y: Effects of environmental tobacco smoke on urinary cotinine excretion in nonsmokers. Evidence for passive smoking. N Engl J Med 1984; 311: 828-32.
52. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y: Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 1984; 38: 335-9.
53. Thompson SG, Stone R, Nanchahal K, Wald NJ: Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke. Thorax 1990; 45: 356-61.
54. Roussel G, Le Quang NT, Migueres ML, Roche D, Mongin-Charpin D, Chretien J, Ekindjian OG: Interpretation of the values of urinary cotinine m smokers and non-smokers. Rev Mal Respir 1991; 8: 225-32.
55. Barbier C, Houdret N, Vittrant C, Deschildre A, Turck D: Study of passive smoking measured by urinary cotinine in maternal and child protective health centers in North-Pas-de-Calais. Arch Pediatr 2000; 7: 719-24.
56. Schneider JM, Capolaghi B, Briancon S, Covi G, Merlin JP, Leveau PH: Passive smoking in children. Its detection by the assay of urinary cotinine. Arch Fr Pediatr 1993; 50: 567-71.
57. Knight JM, Eliopoulos C, Klein J, Greenwald M, Koren G: Passive smoking in children. Racial differences in systemic exposure to cotinine by hair and urine analysis. Chest 1996; 109: 446-50.
58. Preston AM, Ramos LJ, Calderon C, Sahai H: Exposure of Puerto Rican children to environmental tobacco smoke. Prev Med 1997; 26: 1-7.
59. rd, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301: 594-8.
60. Greaves R, Trotter L, Brennecke S, Janus E: A simple high-pressure liquid chromatography cotinine assay: validation of smoking status in pregnant women. Ann Clin Biochem 2001; 38: 333-8.
61. Coultas DB, Howard CA, Peake GT, Skipper BJ, Samet JM: Discrepancies between self-reported and validated cigarette smoking in a community survey of New Mexico Hispanics. Am Rev Respir Dis 1988; 137: 810-4.
62. Feyerabend C, Higenbottam T, Russell MA: Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J 1982; 284: 1002-4.
63. Jordanov JS: Cotinine concentrations in-amniotic fluid and urine of smoking, passive smoking and non-smoking pregnant women at term and in the urine of their neonates on 1st day of life. Eur J Pediatr 1990; 149: 734-7.
64. Jarvis MJ, Russell MA, Feyetabend C, Eiser JR, Morgan M, Gammage P, Gray EM: Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of nonsmoking schoolchildren. Br Med J 1985; 291: 927-9.
65. Coultas DB, Howard CA, Peake GT, Skipper BJ, Samet JM: Salivary cotinine levels and involuntary tobacco smoke exposure in children and adults in New Mexico. Am Rev Respir Dis 1987; 136: 305-9.
66. Al-Delaimy WK, Crane J, Woodward A: Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine? J Epidemiol Community Health 2002; 56: 66-71.
67. Eliopoulos C, Klein J, Chitayat D, Greenwald M, Koren G: Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking. Clin Invest Med 1996; 19: 231-42.
68. Al-Delaimy WK, Mahoney GN, Speizer FE, Willett WC: Toenail nicotine levels as a biomarker of tobacco smoke exposure. Cancer Epidemiol Biomarkers Prev 2002; 11: 1400-4.
69. Hill P, Haley NJ, Wynder EL: Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis 1983; 36: 439-49.
70. Bowler RG: Determination of thiocyanate in blood serum. Biochemistry Journal 1944; 38: 385-8.
71. Densen PM, Davidow B, Bass HE, Jones EW: A chemical test for smoking exposure. Arch Environ Health 1967; 14: 865-74.
72. rd, Pierson WP: Passive smoking and thiocyanate concentrations in pregnant women and newborns. Obstet Gynecol 1984; 63: 519-22.
73. Chen Y, Pederson LL, Lefcoe NM: Exposure to environmental tobacco smoke (ETS) and serum thiocyanate level in infants. Arch Environ Health 1990; 45: 163-7.
74. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR: Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993; 85: 474-8.
75. Crawford FG, Mayer J, Santella RM, Cooper TB, Ottman R, Tsai WY, Simon-Cereijido G, Wang M, Tang D, Perera FP: Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst 1994; 86: 1398-402.
76. Romand G, Sgambato A, Flamini G, Boninsegna A, Milito S, Ardito R, Cittadini A: Evaluation of 8-hydroxydeoxyguanosine in human oral cells: the importance of tobacco smoke and urban environment. Anticancer Res 2000; 20: 3801-5.
77. Romano G, Sgambato A, Boninsegna A, Flamini G, Curigliano G, Yang Q, La Gioia V, Signorelli C, Ferro A, Capelli G, Santella RM, Cittadini A: Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay. Cancer Epidemiol Biomarkers Prev 1999; 8: 91-6.
78. Wjst M, Heinrich J, Liu P, Dold S, Wassmer G, Merkel G, Huelsse C, Wichmann HE: Indoor factors and IgE levels in children. Allergy 1994; 49: 766-71.
79. Ngogang J, Eben-Moussi E, Raisonnier A: Salivary, urinary and plasma thiocyanate in smokers and non-smokers. Pathol Biol 1983; 31: 155-60.